Loading ...

Geo Gaile

Immune Tolerance Network

Assessment Group

ggaile@immunetolerance.org

Work:

415-854-7485

Mobile:

Address:

Immune Tolerance Network

Committees:

,

Studies:

ITN029ST

-

Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients

ITN030ST

-

Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant

ITN036ST

-

Renal Allograft Tolerance through Mixed Chimerism

ITN039ST

-

Research Study of ATG and Rituximab in Renal Transplantation

ITN040CT

-

Immunosuppressive Medications for Participants in ITN005CT

ITN054ST

-

BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance

ITN056ST

-

Evaluation of Donor Specific Immune Senescence and Exhaustion as Biomarkers of Tolerance Post Liver Transplantation

ITN063ST

-

A Cohort Study of Operationally Tolerant Allograft Recipients

ITN069ST

-

Renal Allograft Tolerance Through Mixed Chimerism And Co-Stimulation Blockade With Belatacept

ITN090ST

-

Daratumumab and Belatacept for Desensitization

ITN095AI

-

Siplizumab in T1DM

ITN100ST

-

Siplizumab for Liver Transplant Tolerance

ITN507ST

-

Study of Tolerant Kidney Transplant Recipients

ITN524ST-CTOT-12

-

Associating Renal Transplantation With the ITN Signature of Tolerance

Bio:

Admin Links

Shortcuts

ITN Documents

Links